- Home
- ORGO vs CNDT Comparison
ORGO vs CNDT Comparison
Compare ORGO & CNDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- CNDT
- Stock Information
- Founded
- ORGO 1985
- CNDT 2016
- Country
- ORGO United States
- CNDT United States
- Employees
- ORGO N/A
- CNDT N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- CNDT Business Services
- Sector
- ORGO Health Care
- CNDT Consumer Discretionary
- Exchange
- ORGO Nasdaq
- CNDT Nasdaq
- Market Cap
- ORGO 465.6M
- CNDT 381.9M
- IPO Year
- ORGO N/A
- CNDT N/A
- Fundamental
- Price
- ORGO $4.32
- CNDT $2.69
- Analyst Decision
- ORGO Hold
- CNDT
- Analyst Count
- ORGO 1
- CNDT 0
- Target Price
- ORGO $6.00
- CNDT N/A
- AVG Volume (30 Days)
- ORGO 918.2K
- CNDT 1.2M
- Earning Date
- ORGO 08-07-2025
- CNDT 08-06-2025
- Dividend Yield
- ORGO N/A
- CNDT N/A
- EPS Growth
- ORGO N/A
- CNDT N/A
- EPS
- ORGO N/A
- CNDT 1.54
- Revenue
- ORGO $458,760,000.00
- CNDT $3,186,000,000.00
- Revenue This Year
- ORGO $1.10
- CNDT N/A
- Revenue Next Year
- ORGO $9.93
- CNDT $2.53
- P/E Ratio
- ORGO N/A
- CNDT $1.73
- Revenue Growth
- ORGO 5.35
- CNDT N/A
- 52 Week Low
- ORGO $2.28
- CNDT $1.90
- 52 Week High
- ORGO $6.71
- CNDT $4.90
- Technical
- Relative Strength Index (RSI)
- ORGO 68.34
- CNDT 55.51
- Support Level
- ORGO $3.59
- CNDT $2.70
- Resistance Level
- ORGO $4.70
- CNDT $2.83
- Average True Range (ATR)
- ORGO 0.23
- CNDT 0.11
- MACD
- ORGO 0.12
- CNDT -0.01
- Stochastic Oscillator
- ORGO 81.15
- CNDT 59.26
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.